Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🚫 This provider appears on the OIG List of Excluded Individuals/Entities (LEIE)
Exclusion type: 1128a1 · Date: 20230620 · State: CA
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
4,931
Total Claims
$578K
Drug Cost
665
Beneficiaries
$869
Cost/Patient
Risk Score Breakdown 40/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-19%
Opioid rate vs peers
1.8% vs 2.2% avg
-38%
Cost per patient vs peers
$869 vs $1,411 avg
+28%
Brand preference vs peers
13.6% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.8%
Opioid Rate
89
Opioid Claims
$1,898
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 666 claims · $444K
Generic: 4,215 claims · $132K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 73 | $55K |
| Sitagliptin Phosphate | 21 | $28K |
| Empagliflozin | 39 | $23K |
| Linaclotide | 17 | $13K |
| Insulin Glargine,hum.Rec.Anlog | 25 | $13K |
| Linagliptin | 14 | $13K |
| Insulin Aspart | 11 | $8,416 |
| Insulin Glargine,hum.Rec.Anlog | 14 | $6,657 |
| Gabapentin | 147 | $5,559 |
| Atorvastatin Calcium | 259 | $5,245 |
| Insulin Aspart | 15 | $4,679 |
| Amlodipine Besylate | 249 | $3,924 |
| Metformin Hcl | 222 | $3,735 |
| Omeprazole | 161 | $3,721 |
| Olanzapine | 56 | $3,517 |
Prescribing Profile
Patient Profile
74
Avg Age
54%
Female
1.55
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About